Can a blood treatment boost IVF success? new trial investigates

NCT ID NCT07306871

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether platelet-rich plasma (PRP), made from a woman's own blood, can improve pregnancy rates in those who have had multiple failed embryo transfers. 180 women will receive PRP either as an injection into the uterus lining or as a simple infusion, and their outcomes will be compared to a group receiving standard care. The goal is to see which method works better for helping embryos implant successfully.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
platelet-rich plasma (PRP)
What this could lead to
If it works, this could offer a simple, low-cost way to improve pregnancy rates for women who have repeatedly failed embryo transfers.
What could go wrong
This is a small, early-stage trial with 180 participants, and PRP is not a standard treatment. Results may not show a clear benefit, and the procedure carries minor risks like infection or discomfort.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COMPARE BETWEEN SUBENDOMETRIAL INJECTION AND INTRAUTERINE INFUSION OF PRP IN RECURRENT IMPLANTATION FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Minia University

    Minya, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.